Free Trial
Ami Fadia

Ami Fadia Analyst Performance

Sr Biotech Equity Research Analyst at Needham & Company LLC

Ami Fadia is a stock analyst at Needham & Company LLC focused in the medical sector, covering 26 publicly traded companies. Over the past year, Ami Fadia has issued 75 stock ratings, including buy and hold recommendations. While full access to Ami Fadia's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Ami Fadia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
155 Last 6 Years
Buy Recommendations
90.00% 135 Buy Ratings
Companies Covered
26 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy90.0%135 ratings
Hold10.0%15 ratings
Sell0.0%0 ratings

Out of 150 total stock ratings issued by Ami Fadia at Needham & Company LLC, the majority (90.0%) have been Buy recommendations, followed by 10.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
26 companies

Ami Fadia, an analyst at Needham & Company LLC, currently covers 26 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
25 companies
96.2%
Manufacturing
1 company
3.8%

Ami Fadia of Needham & Company LLC specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
18 companies
69.2%
MED - DRUGS
5 companies
19.2%
Miscellaneous
1 company
3.8%
MED - OUTP/HM CRE
1 company
3.8%
BIOTECHNOLOGY
1 company
3.8%

About Ami Fadia

Ami Fadia joined Needham and Company in May 2021 covering Biotechnology with a focus on targeted oncology and neuroscience. Prior to joining Needham, Ami spent four years as a Managing Director and Senior Analyst at SVB Leerink and previous to that spent six years at UBS where she most recently held the position of Senior Analyst. Ami also spent time working in industry as Head of Strategy & Operations at Sandoz where she was responsible for building a high performing team responsible for strategic planning, sales force strategy, training, project management, budgeting, and business development. Ami began her career in consulting working at KPMG and then McKinsey & Company in their healthcare practice. Ami holds an MBA from the Kellogg School of Management, her Bachelor’s of Commerce from the Shri Ram College, Delhi University and is a member of the Institute of Chartered Accountants of India.
Follow on LinkedIn

Ami Fadia's Ratings History at Needham & Company LLC

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Biogen Inc. stock logo
BIIB
Biogen
6/8/2026Upgrade$195.34$255.00Buy
Alkermes plc stock logo
ALKS
Alkermes
5/6/2026Boost Price Target$36.25$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$230.28$255.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/1/2026Boost Price Target$205.83$255.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
4/14/2026Reiterated Rating$343.28$510.00Buy
Maplight Therapeutics, Inc. stock logo
MPLT
Maplight Therapeutics
4/8/2026Initiated Coverage$24.14$37.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/6/2026Reiterated Rating$133.30$185.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/31/2026Reiterated Rating$1.93$8.00Buy
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
3/31/2026Downgrade$27.58Hold
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/18/2026Lower Price Target$5.07$15.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
3/9/2026Reiterated Rating$3.39$14.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/9/2026Reiterated Rating$5.33$11.00Buy
GH Research PLC stock logo
GHRS
GH Research
3/6/2026Boost Price Target$15.17$32.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/6/2026Downgrade$21.18Hold
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/25/2026Lower Price Target$12.02$17.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2026Lower Price Target$28.19$44.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/23/2026Reiterated Rating$183.72$225.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/12/2026Lower Price Target$137.44$185.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/4/2026Boost Price Target$310.52$510.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
1/12/2026Boost Price Target$161.13$235.00Buy
GH Research PLC stock logo
GHRS
GH Research
1/6/2026Set Price Target$15.46$29.00
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
1/5/2026Reiterated Rating$286.40$460.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/5/2026Reiterated Rating$178.69$225.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
1/5/2026Reiterated Rating$26.29$34.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
1/5/2026Reiterated Rating$13.64Buy
GH Research PLC stock logo
GHRS
GH Research
1/5/2026Reiterated Rating$13.24$19.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
12/31/2025Boost Price Target$148.79$169.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/8/2025Boost Price Target$247.99$315.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
12/8/2025Reiterated Rating$39.79Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/5/2025Set Price Target$253.44$304.00
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/1/2025Reiterated Rating$196.71$250.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
11/24/2025Reiterated Rating$34.67$42.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
11/24/2025Reiterated Rating$8.56$16.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
11/6/2025Boost Price Target$22.33$29.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/6/2025Boost Price Target$59.34$72.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Reiterated Rating$135.75$154.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
10/29/2025Boost Price Target$147.38$184.00Buy
Alkermes plc stock logo
ALKS
Alkermes
10/29/2025Boost Price Target$31.00$44.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
10/28/2025Boost Price Target$2.69$8.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
10/22/2025Downgrade$18.58Hold
Goldman Sachs just told you what to buy (most people missed it) (Ad)

Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.tc pixel

See the stock positioned to solve AI's biggest power crisis
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
10/16/2025Boost Price Target$175.68$250.00Buy
GH Research PLC stock logo
GHRS
GH Research
10/13/2025Initiated Coverage$12.59$19.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
10/13/2025Set Price Target$11.81$28.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
10/13/2025Initiated Coverage$5.10$12.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
10/13/2025Initiated Coverage$5.40$12.00Buy
GH Research PLC stock logo
GHRS
GH Research
10/13/2025Initiated Coverage$12.96$19.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
10/13/2025Initiated Coverage$12.25$28.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
9/30/2025Reiterated Rating$6.75$11.00Buy
Merus N.V. stock logo
MRUS
Merus
9/29/2025Downgrade$94.15$96.00Hold
Biogen Inc. stock logo
BIIB
Biogen
9/24/2025Reiterated Rating$139.31Hold
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
9/24/2025Lower Price Target$28.74$41.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
9/24/2025Lower Price Target$20.84$28.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
9/22/2025Boost Price Target$145.23$170.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
9/15/2025Boost Price Target$8.49$11.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
9/11/2025Boost Price Target$40.45$66.00Buy
Alkermes plc stock logo
ALKS
Alkermes
9/9/2025Set Price Target$26.93$43.00
Biogen Inc. stock logo
BIIB
Biogen
9/4/2025Reiterated Rating$141.62Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/28/2025Reiterated Rating$124.43$202.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
8/26/2025Reiterated Rating$5.95$8.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/20/2025Reiterated Rating$119.20$202.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
8/7/2025Lower Price Target$36.67$56.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
8/6/2025Lower Price Target$6.88$16.00Buy
Merus N.V. stock logo
MRUS
Merus
8/6/2025Lower Price Target$67.45$96.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/4/2025Reiterated Rating$103.02$150.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/29/2025Reiterated Rating$26.15$45.00Buy
Alkermes plc stock logo
ALKS
Alkermes
7/21/2025Reiterated Rating$29.22$45.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
6/26/2025Reiterated Rating$22.50$30.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
6/24/2025Reiterated Rating$40.42$57.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/18/2025Reiterated Rating$1.82$9.00Buy
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
6/17/2025Reiterated Rating$7.49Hold
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
6/16/2025Reiterated Rating$6.70Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
6/12/2025Reiterated Rating$44.60$80.00Buy
Biogen Inc. stock logo
BIIB
Biogen
6/12/2025Reiterated Rating$133.06Hold
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/11/2025Reiterated Rating$113.00$202.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/9/2025Lower Price Target$111.91$150.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
6/5/2025Reiterated Rating$1.96$9.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
6/3/2025Reiterated Rating$108.29$202.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
6/2/2025Downgrade$101.15$130.00Hold
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
5/28/2025Initiated Coverage$12.77$35.00Buy
Alkermes plc stock logo
ALKS
Alkermes
5/28/2025Initiated Coverage$29.90$45.00Buy
Merus N.V. stock logo
MRUS
Merus
5/19/2025Reiterated Rating$41.56$75.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
5/19/2025Boost Price Target$22.26$30.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
5/13/2025Reiterated Rating$0.72$5.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/8/2025Reiterated Rating$37.66$57.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
5/8/2025Reiterated Rating$9.47$19.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
5/7/2025Lower Price Target$6.99$27.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/7/2025Reiterated Rating$111.17$200.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
5/6/2025Reiterated Rating$29.96$49.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
5/5/2025Reiterated Rating$40.24$80.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
5/2/2025Reiterated Rating$9.08$29.00Buy
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/28/2025Lower Price Target$87.20$130.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
4/25/2025Reiterated Rating$7.79Hold
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
4/15/2025Upgrade$94.89$138.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
4/10/2025Reiterated Rating$110.12$210.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
4/10/2025Reiterated Rating$1.29$12.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
4/10/2025Reiterated Rating$0.76$5.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
4/9/2025Reiterated Rating$6.59$19.00Buy
Merus N.V. stock logo
MRUS
Merus
4/9/2025Reiterated Rating$34.89$83.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
4/9/2025Reiterated Rating$6.38$30.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
4/8/2025Reiterated Rating$14.61$28.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
4/8/2025Reiterated Rating$80.20$133.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
4/8/2025Reiterated Rating$31.53$85.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/8/2025Reiterated Rating$31.40$59.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
4/8/2025Reiterated Rating$28.91$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4/1/2025Reiterated Rating$116.63$153.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
3/21/2025Reiterated Rating$1.65$12.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/11/2025Reiterated Rating$9.79$30.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
3/5/2025Reiterated Rating$140.69$210.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/4/2025Reiterated Rating$1.41$5.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
3/3/2025Lower Price Target$38.60$85.00Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
3/3/2025Reiterated Rating$7.91$19.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3/3/2025Reiterated Rating$129.15$153.00Buy
Merus N.V. stock logo
MRUS
Merus
2/28/2025Lower Price Target$46.22$83.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
2/27/2025Reiterated Rating$18.96$28.00Buy
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
2/27/2025Lower Price Target$40.50$59.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
2/26/2025Reiterated Rating$11.10$30.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
2/26/2025Reiterated Rating$11.82$32.00Buy
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/26/2025Boost Price Target$139.67$210.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2025Reiterated Rating$34.18$50.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$128.09$153.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/19/2025Lower Price Target$36.76$50.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
2/13/2025Reiterated Rating$103.56$133.00Buy
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
2/12/2025Reiterated Rating$7.19Hold
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/10/2025Reiterated Rating$86.88$150.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/10/2025Reiterated Rating$131.74$133.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/7/2025Reiterated Rating$150.51Hold
Immuneering Corporation stock logo
IMRX
Immuneering
2/6/2025Reiterated Rating$2.03$12.00Buy
Blueprint Medicines Corporation stock logo
BPMC
Blueprint Medicines
1/13/2025Reiterated Rating$87.43$135.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
1/13/2025Reiterated Rating$35.91$52.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
1/13/2025Reiterated Rating$14.75$32.00Buy
Immuneering Corporation stock logo
IMRX
Immuneering
1/13/2025Reiterated Rating$1.99$15.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
1/13/2025Reiterated Rating$11.77$33.00Buy